Paclitaxel 150mg/25ml solution for infusion vials
NHS hospitals in England used £21,778,118 of indicative cost of Paclitaxel 150mg/25ml solution for infusion vials in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 86.7% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Paclitaxel 150mg/25ml solution for infusion vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Paclitaxel 150mg/25ml solution for infusion vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Christie Nhs Foundation Trust | £2,943,414 |
| Norfolk & Norwich University Hpl Nhs Trt | £1,064,232 |
| United Lincolnshire Hospitals Nhs Trust | £945,078 |
| South Tees Hosp Nhs Foundation Trust | £932,418 |
| Mid Yorkshire Hospitals Nhs Trust | £814,648 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £801,828 |
| Somerset P/Ship Nhs Foundation Trust | £717,458 |
| Nottingham University Hospitals Trust | £671,132 |
| London North West Healthcare Nhs Trust | £621,369 |
| University Hpls Coventry & Warwick Trust | £612,616 |
The primary-care picture
Paclitaxel is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Paclitaxel medicine page.